Bilaal.Raja
Company record

VKTX  Viking Therapeutics, Inc.

Trailing twelve months to 2026-06-30, as filed 2026-07-29 and not restated since.
Healthcare

Scale

Market cap
$3.5bn
Revenue TTM
$0m
Net income TTM
$-535m
Free cash flow
—
Composite score
—
Sector rank
#1260

Valuation

P / E
—
EV / EBITDA
—
EV / sales
—
FCF yield
—
Yield vs 10-yr
-20.59pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
—
EBITDA margin
—
ROE
-131.0%
ROIC
—
Revenue growth
—

Insider activity, last 90 days

Net open-market
$-6.27m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.